Biomax Informatics Puts BioXM Platform Through Paces with European COPD Project | GenomeWeb

Biomax Informatics said recently that its knowledge integration platform, BioXM, is being used by scientists involved in the Synergy-COPD project — a research effort funded by the European Commission's Seventh Framework Program that aims to study the underlying mechanisms of chronic obstructive pulmonary disease phenotypes associated with poor prognosis.

Biomax says it has met its first milestone for the project by developing an approach based on BioXM that combines different sources of biological data with clinical information.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.